Citichem India
Chemicals
544324 BSE
₹16.00
Close ·
- P/E
- 40.00
Close 29 Oct 2026 ₹16.00 −12.00 −42.9% 1Y
Start ₹28.00
Key Fundamentals
SMEChemicals & PetrochemicalsChemicalsPrice-based figures at the close · TTM
- ROCE
- 7.18%
- Debt to Equity
- 0.37
- EPS (TTM)
- ₹0.40
- Book Value
- ₹31.03
- Market Cap
- —
- P/E (TTM)
- 40.00
- P/B
- 0.52
- ROE
- 4.85%
- Dividend Yield
- 0.00%
- EBITDA
- ₹2.00 Cr
- 52W High
- ₹31.00
- 52W Low
- ₹12.00
Key Insights
Strengths
1- Stock is trading at 0.52 times its book value
Weaknesses
7- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -39.4% over past five years.
- Company has a low return on equity of 8.78% over last 3 years.
- Contingent liabilities of Rs.221 Cr.
- Earnings include an other income of Rs.0.70 Cr.
- Company has high debtors of 918 days.
- Working capital days have increased from 164 days to 289 days
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Neutral | 7 | 5 | 7 |
| Oscillators | Bullish | 1 | 5 | 3 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bullish
Bearish
1
Neutral
5
Bullish
3
Overall
Neutral
Bearish
7
Neutral
5
Bullish
7
Moving Averages
Strong Bearish
Bearish
6
Neutral
0
Bullish
4
Key readings
- RSI (14)
- 51.86
- Neutral
- MACD (12,26,9)
- 0.24
- Bullish
- SMA (50)
- 15.68
- Bullish
- SMA (200)
- 21.02
- Bearish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 10Y | Irregular period |
|---|---|
| 5Y | −39.35% |
| 3Y | −10.96% |
| 1Y | −72.82% |
Net profit
| 10Y | Irregular period |
|---|---|
| 5Y | +35.37% |
| 3Y | +40.57% |
| 1Y | −18.70% |
Operating cash flow
| 10Y | Irregular period |
|---|---|
| 5Y | Turned negative |
| 3Y | Turned negative |
| 1Y | Outflow narrowed by ₹6.40 Cr |
Operating margin· change in pp
| 10Y | Irregular period |
|---|---|
| 5Y | +8.74 pp |
| 3Y | +6.09 pp |
| 1Y | +5.88 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2014 | ₹0.00 Cr |
|---|---|
| Mar 2020 | ₹127 Cr |
| Mar 2021 | ₹180 Cr |
| Mar 2022 | ₹85.22 Cr |
| Mar 2023 | ₹20.94 Cr |
| Mar 2024 | ₹19.61 Cr |
| Mar 2025 | ₹54.37 Cr |
| Mar 2026 | ₹14.78 Cr |
Net profit by year
| Mar 2014 | −₹0.02 Cr |
|---|---|
| Mar 2020 | ₹0.20 Cr |
| Mar 2021 | ₹0.22 Cr |
| Mar 2022 | ₹0.24 Cr |
| Mar 2023 | ₹0.36 Cr |
| Mar 2024 | ₹1.39 Cr |
| Mar 2025 | ₹1.23 Cr |
| Mar 2026 | ₹1.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 1.67 | 52.7 | 10.1 | 4.68 |
| Expenses | 1.5 | 51.25 | 9.57 | 3.9 |
| Operating Profit | 0.17 | 1.45 | 0.53 | 0.78 |
| OPM % | 10.18% | 2.75% | 5.25% | 16.67% |
| Other Income | 0 | 0.36 | 0.67 | 0.03 |
| Interest | 0 | 0.31 | 0.26 | 0.32 |
| Depreciation | 0.01 | 0 | 0.03 | 0.03 |
| PBT | 0.16 | 1.5 | 0.91 | 0.46 |
| Tax % | 25% | 26% | 25.27% | 30.43% |
| Net Profit | 0.12 | 1.11 | 0.68 | 0.32 |
| EPS (₹) | 0.24 | 1.63 | 1 | 0.47 |
Profit & Loss
₹ Cr| Particulars | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 127 | 180 | 85.22 | 20.94 | 19.61 | 54.37 | 14.78 |
| Expenses | 0.02 | 127 | 180 | 84.84 | 20.36 | 17.81 | 52.75 | 13.47 |
| Operating Profit | −0.02 | 0.28 | 0.21 | 0.38 | 0.58 | 1.8 | 1.62 | 1.31 |
| OPM % | — | 0.22% | 0.12% | 0.45% | 2.77% | 9.18% | 2.98% | 8.86% |
| Other Income | 0 | 0.01 | 0.11 | 0.06 | 0 | 0 | 0.36 | 0.7 |
| Interest | 0 | 0.01 | 0 | 0.1 | 0.06 | 0.07 | 0.31 | 0.58 |
| Depreciation | 0 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 | 0.01 | 0.06 |
| PBT | −0.02 | 0.27 | 0.3 | 0.32 | 0.51 | 1.71 | 1.66 | 1.37 |
| Tax % | 0% | 25.93% | 26.67% | 28.12% | 29.41% | 18.71% | 25.9% | 27.01% |
| Net Profit | −0.02 | 0.2 | 0.22 | 0.24 | 0.36 | 1.39 | 1.23 | 1 |
| EPS (₹) | — | — | — | 0.48 | 0.72 | 2.78 | 1.81 | 1.47 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.07 | 0.07 | 0.07 | 5 | 5 | 5 | 6.8 | 6.8 |
| Reserves | 0.15 | 0.31 | 0.53 | 0.77 | 1.13 | 2.52 | 13.3 | 14.3 |
| Borrowings | 0.11 | 0.37 | 0 | 1.11 | 1.1 | 1.08 | 5.39 | 7.72 |
| Other Liabilities | 0.01 | 31.98 | 72.62 | 84.55 | 72.5 | 60.73 | 44.43 | 25.98 |
| Total Liabilities | 0.34 | 32.73 | 73.22 | 91.43 | 79.73 | 69.33 | 69.92 | 54.8 |
| Fixed Assets | 0.01 | 0.08 | 0.09 | 0.08 | 0.1 | 0.1 | 0.06 | 0.93 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0.32 | 32.64 | 73.13 | 91.35 | 79.63 | 69.23 | 69.86 | 53.87 |
| Total Assets | 0.34 | 32.73 | 73.22 | 91.43 | 79.73 | 69.33 | 69.92 | 54.8 |
Cash Flow
₹ Cr| Particulars | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating | — | 0.37 | 0.38 | −5.95 | 0.28 | 0.49 | −11.59 | −5.19 |
| Investing | — | −0.01 | −0.02 | −0.01 | −0.04 | 0 | 0.1 | −0.36 |
| Financing | — | −0.42 | −0.37 | 5.94 | −0.07 | −0.08 | 15.35 | 1.75 |
| Net Cash Flow | — | −0.07 | −0.02 | −0.03 | 0.17 | 0.41 | 3.86 | −3.8 |
| Free Cash Flow | — | 0.36 | 0.35 | −5.96 | 0.24 | 0.49 | −11.56 | −6.11 |
| CFO/EBITDA | — | 175 | 133 | −1,566 | 48 | 28 | −715 | −390 |
Ratios
| Particulars | Mar 2014 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | 5.53 | 68.05 | 199 | 596 | 569 | 343 | 918 |
| Inventory Days | — | 76.06 | 70.95 | 180 | 857 | 849 | 45.66 | 231 |
| Days Payable | — | 92.27 | 148 | 368 | 1,378 | 1,348 | 315 | 854 |
| Cash Conversion Cycle | — | −10.68 | −9.47 | 11.3 | 74.9 | 70.51 | 73.15 | 295 |
| Working Capital Days | — | 1.63 | 0.85 | 28.7 | 118 | 145 | 58.2 | 289 |
| ROCE % | — | — | 44.44% | 11.23% | 8.08% | 22.49% | 11.56% | 7.18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Citichem insights
51 extracted metrics across FY14–FY26.
Documents
- General announcements 9 Oct 2026
Frequently Asked Questions about Citichem India
What does Citichem India Ltd do?
Incorporated in 1992, Citichem India Ltd is in the business of trading of chemicals.
Where is Citichem India Ltd (CITICHEM) listed?
Citichem India Ltd trades under code 544324 on the BSE.
Which sector does Citichem India Ltd belong to?
Citichem India Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the PE ratio of Citichem India Ltd?
Citichem India Ltd trades at a PE ratio of 40.00 as of 29 Oct 2026, on earnings per share of ₹0.4, against a book value of ₹31.03 per share.
What is the 52-week high and low of Citichem India Ltd?
Over the last 52 weeks Citichem India Ltd has traded between ₹12 and ₹31 as of 29 Oct 2026.
What is the Return on Equity (ROE) of Citichem India Ltd?
Citichem India Ltd reported a return on equity of 4.85%. Its debt-to-equity ratio is 0.37.
Company Information
Incorporated in 1992, Citichem India Ltd is in the business of trading of chemicals.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544324.md for Citichem India Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.